Show simple item record

dc.contributor.authorPlessis, Stefan S du
dc.date.accessioned2021-08-04T06:57:40Z
dc.date.available2021-08-04T06:57:40Z
dc.date.issued2020
dc.identifier.other204-2020.85
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/396
dc.description.abstractAbstract: Severe acute respiratory syndrome coronavirus 2 (SARS􀀀 COV-2), a single-stranded RNA virus, was found to be the causal agent of the disease called coronavirus disease. During December 2019, China informed the World Health Organization (WHO) of an outbreak of cases of pneumonia of unknown etiology, which caused severeacute respiratory distress. The disease was termed coronavirus disease 2019 (Covid-19). Due to alarming levels of spread and severity, on the 11th of March 2020, the WHO declared the outbreak as a global pandemic. As of September 14, 2020, more than 29 million cases have been reported, with over 900,000 deaths globally. Since the outbreak, although not conclusive, discoveries have been made regarding the understanding of the epidemiology, etiology, clinical features, clinical treatment, and prevention of the disease. SARS􀀀 COV-2 has been detected in saliva, respiratory fluids, blood, urine, and faeces. Findings are however controversial regarding its presence in the semen or the testis. Hence, this review aimed to further analyse the literature concerning (i) the effects of previously identified human coronaviruses on male fertility (ii) the impact of Covid-19 on male fertility and (iii) the implication for general health in terms of infection and transmission.en_US
dc.language.isoenen_US
dc.subjectSARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectMale fertilityen_US
dc.subjectMERS-COVen_US
dc.titleSARS-COV-2 (Covid-19) and male fertility: Where are we?en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record